Microbiology Testing Market Size

Microbiology Testing Market size was valued at USD 4.59 billion in 2024 and is expected to cross USD 10.73 billion by the end of 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of microbiology testing is estimated at USD 4.84 billion.

The market growth is owing to the increasing prevalence of various infectious diseases such as sexually transmitted diseases (STDs) and human immunodeficiency virus (HIV). A WHO report estimates that over 1 million STIs are acquired each day around the world. As of 2021, 650 000 people have died from HIV-related causes and 1.5 million have contracted the virus. Microbiology testing is used to diagnose and monitor infectious diseases. The process consists of cultivating and identifying bacteria, viruses, and fungi from an individual's body, such as blood or saliva, and then determining if they are causing illness.

Moreover, the increasing urinary tract infections (UTI) is soaring the demand for microbiology testing. Prevalence of UTIs is predicted to be between 150 and 230 million worldwide every year. Number of women who suffer from UTI in the United States is 38%, making it the most common infection among women. UTIs are caused by bacteria, such as E. coli, which can be identified through microbiology testing such as Midstream urine culture (MSU).